Kangmei Pharma | 600518 - Net Income

Stock Price
1.61
Daily Change
-0.01 -0.62%
Monthly
-8.00%
Yearly
-18.69%
Q2 Forecast
1.59

Kangmei Pharma reported CNY-3.82M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.16M 108K Sep/2025
Avita Medical AUD -11.62M 1.7M Dec/2025
Cspc Pharmaceutical CNY 370.72M 592.81M Dec/2025
Dianthus Therapeutics USD -64.43M 27.67M Dec/2025
Genomma Lab Internacional MXN 494.65M 175.01M Mar/2026
Hypermarcas BRL 450.99M 6.65M Dec/2025
Ionis Pharmaceuticals USD -93M 136M Mar/2026
IQVIA Holdings USD 274M 240M Mar/2026
Jiangsu Hengrui CNY 2.28B 322.38M Mar/2026
Kangmei Pharma CNY -3.82M 12.21M Sep/2025
Moderna USD -1.34B 517M Mar/2026
Organon & Co USD -205M 365M Dec/2025
Revvity USD 40.72M 57.65M Mar/2026
Sh Fosun Pharma CNY 870.83M 23.56M Mar/2026
Tectonic Therapeutic USD -19.23M 186K Dec/2025
Viatris USD 176.4M 516.5M Mar/2026
Wuxi Apptec CNY 4.65B 2.42B Mar/2026
Xeris Pharmaceuticals USD 11.08M 10.46M Dec/2025
Zz Pientze Pharmaceu CNY 743.48M 56.45M Mar/2026